Siegfried Malta Ltd focuses on supporting our customers, with contract development and manufacturing services in the pharmaceutical oral solid dosage industry. Recently, Siegfried Malta Ltd and the General Workers Union signed their first Collective Agreement. The signing of the Collective Agreement has coincided with the Siegfried’s 10th Year anniversary, as it has been 10 years since Siegfried opened its operations in Malta. Siegfried Malta Ltd employs over 130 employees in Malta and this first Collective Agreement consolidates further the company’s strong commitment to be an attractive and reliable employer in Malta. Furthermore, it aims to nurture and develop the right skills of its workforce, retain its employees, and attract new employees that would like to start or pursue a career in the pharmaceutical industry. This collective agreement covers a number of benefits for the employees, including the opportunity for them to contribute to a pension scheme.
The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, the USA, Malta, China, Germany and France. At the end of 2016, Siegfried reported annual sales of CHF 718 million and employs approximately 2300 employees at nine locations on three continents. Siegfried Holding AG is listed on the Swiss Exchange (SIX: SFZN).
Siegfried is active in both the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediates and controlled substances, and provides development and production services for finished dosage forms including sterile filling.